We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Karuna Therapeutics Inc
4 watching
Current Price
$192.15
$0.16
(0.08%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
6,599.58M
52-Week High
278.2532
52-Week Low
92.26
Average Volume
0.27M
Dividend Yield
--
P/E Ratio
--
Market Capitalization6,599.58M52-Week High278.253252-Week Low92.26Average Volume0.27MDividend Yield--P/E Ratio--What does the Karuna Therapeutics Inc do?
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phase Ib clinical trial for the treatment of central nervous system disorders, such as cognitive and negative symptoms, Alzheimer's, and pain. It also focuses on developing other muscarinic-targeted drug candidates. Karuna Pharmaceuticals, Inc. has a license agreement with Eli Lilly and Company; and patent license agreement with PureTech Health LLC. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics, Inc. operates as a subsidiary of PureTech Health plc.
Read More
How much money does Karuna Therapeutics Inc make?
News & Events about Karuna Therapeutics Inc.
Ticker Report
19days ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) Director James Healy sold 6,027 shares of Karuna Therapeutics stock in a transaction that occurred on Friday, January 13th. The shares were sold at an average price of $199.90, for a total value of $1,204,797.30. Following the completion of ...
Zolmax
26days ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) insider Stephen K. Brannan sold 5,000 shares of the stock in a transaction on Monday, January 9th. The stock was sold at an average price of $197.52, for a total transaction of $987,600.00. Following the completion of the sale, the insider now owns ...
Globe Newswire
1month ago
NEW YORK, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Karuna Therapeutics, Inc. (NASDAQ: KRTX) breached their fiduciary duties to shareholders. The investigation concerns potential self-...
Zolmax
1month ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) insider Stephen K. Brannan sold 5,000 shares of the firms stock in a transaction dated Friday, December 9th. The stock was sold at an average price of $200.76, for a total transaction of $1,003,800.00. Following the sale, the insider now owns 15,000...
Zolmax
2 months ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) COO Andrew Craig Miller sold 15,000 shares of the companys stock in a transaction dated Thursday, December 1st. The stock was sold at an average price of $228.30, for a total transaction of $3,424,500.00. Following the completion of ...
Frequently Asked Questions
Frequently Asked Questions
What is Karuna Therapeutics Inc share price today?
Can Indians buy Karuna Therapeutics Inc shares?
How can I buy Karuna Therapeutics Inc shares from India?
Can Fractional shares of Karuna Therapeutics Inc be purchased?
What are the documents required to start investing in Karuna Therapeutics Inc stocks?
What is today’s traded volume of Karuna Therapeutics Inc?
What is today’s market capitalisation of Karuna Therapeutics Inc?
What is the 52-Week High and Low Range of Karuna Therapeutics Inc?
What percentage is Karuna Therapeutics Inc down from its 52-Week High?
What percentage is Karuna Therapeutics Inc up from its 52-Week Low?
Current Price
$192.15
$0.16
(0.08%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.